Other - Pyridam Farma Tbk PT (IDX:PYFA)

Watchlist Manager

Watchlist

Price: 458 IDR -1.72%

Market Cap: 5.1T IDR

Pyridam Farma Tbk PT
Other

Quarterly

Annual

TTM

Adjust for Inflation

Cash Flow Statement

Pyridam Farma Tbk PT
Other Peer Comparison

Company		Other	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Pyridam Farma Tbk PT IDX:PYFA	Other N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
T	Tempo Scan Pacific Tbk PT IDX:TSPC	Other -Rp131.7B	CAGR 3-Years 28%	CAGR 5-Years 1%	CAGR 10-Years -7%
	Kalbe Farma Tbk PT IDX:KLBF	Other -Rp49B	CAGR 3-Years N/A	CAGR 5-Years 6%	CAGR 10-Years 5%
	Darya-Varia Laboratoria Tbk PT IDX:DVLA	Other N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Soho Global Health Tbk PT IDX:SOHO	Other N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Kimia Farma Tbk PT IDX:KAEF	Other -Rp288.2B	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years -59%

Pyridam Farma Tbk PT
Glance View

Market Cap

5.1T IDR

Industry

Pharmaceuticals

PT Pyridam Farma Tbk engages in the production and development of pharmaceutical medicines, and trading of medical supplies. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,539 full-time employees. The company went IPO on 2001-10-16. The firm operates through two segments: Pharmaceutical Products and Toll Manufacturing Services, and Medical Device Products. Its business consists of production and/or distribution of modern and traditional medicines and distribution of medical devices, such as laboratory equipment and PCR test kits. The company offers products across consumer health, prescription, pyfaesthetic and biomedilab categories. The company produces various kinds of pharmaceuticals products ranging from antibiotics, vitamins and health supplements. The firm offers its products in the form of effervescent tablets, capsules, caplets, syrups and creams. Its prescription production has several properties, such as anti-infection, anti-inflammatory, anti-parkinsonian, anti-epileptic, and other indications. The company provides toll manufacturing services to produce products owned by the Company’s partner companies in accordance with predetermined specifications.

View PYFA Analysis

PYFA Intrinsic Value

Undervaluation 8%

Intrinsic Value

Price

What is Intrinsic Value?

Economic Moat is a concept popularized by Warren Buffett to describe a company's durable competitive advantage. It represents the 'moat' that protects a company from competitors and helps it sustain profitability over the long term. Our analysis of the past 10 years showed that companies with a wide economic moat significantly outperformed the market, delivering +645% returns compared to +189% for the S&P 500.

Our research into Economic Moat performance spans the past 10 years and focuses on companies with a wide economic moat. For this analysis, we calculated the average stock price returns of these companies, comparing them to the performance of the S&P 500 index over the same period.

The results were compelling: wide moat stocks achieved a remarkable +645% average return, compared to +188% for the broader market. This difference highlights the long-term benefits of investing in businesses that can maintain their market position and pricing power over time.

Note: This research does not account for survivorship bias. Past performance is not indicative of future results.

Determining whether a company has an economic moat requires both a deep dive into financial metrics and a qualitative assessment of its competitive position. Our analysts conduct a rigorous evaluation that focuses on identifying structural advantages that enable a company to sustain profitability and defend its market share over the long term.

The process begins with an analysis of a company’s historical financial performance. We assess how consistently the company has generated returns above its cost of capital and whether those returns have been stable or improving. However, financial performance alone doesn’t reveal the full picture. To understand the sources of these advantages, we evaluate five key drivers of economic moats:

Network Effect: We analyze whether the value of a company’s product or service grows as its user base expands. Platforms like payment systems or marketplaces benefit from this self-reinforcing.

Switching Costs: We assess whether customers face significant costs or disruptions when switching to a competitor’s product or service. High switching costs create customer stickiness and provide pricing power.

Intangible Assets: Strong brands, patents, and regulatory licenses can protect a company’s market position by creating barriers for competitors or enabling premium pricing. For example, a well-recognized consumer brand may command higher customer loyalty and margins.

Efficient scale: Occurs when a market is optimally served by one or a few players, making it unprofitable for new entrants to compete. This typically happens in industries with high fixed costs or geographic constraints, such as utilities or pipelines.

Cost Advantage: Companies with structural cost advantages can produce goods or services at a lower cost than their competitors, enabling them to offer competitive pricing or maintain higher margins. These advantages often arise from economies of scale, superior supply chain management, or proprietary technology. Firms like Walmart leverage their massive scale to negotiate better terms with suppliers, allowing them to undercut competitors on price.

By examining these factors in combination with a company’s financial performance and market positioning, we classify each company into one of three categories:

This rigorous evaluation ensures that our moat ratings are both comprehensive and reliable, giving investors the tools they need to make well-informed, long-term decisions.

The AI Assistant may sometimes provide inaccurate information.

Make your own investment decisions or consult a licensed financial advisor.

Pyridam Farma Tbk PT
IDX:PYFA

Pyridam Farma Tbk PT
Other

Pyridam Farma Tbk PT
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Pyridam Farma Tbk PT
Glance View

See Also

Company

Help

Tools

Stocks

52 Week Range	142 645
Price Target

Pyridam Farma Tbk PT IDX:PYFA

Pyridam Farma Tbk PT Other

Pyridam Farma Tbk PT Other Peer Comparison

Competitors Analysis Latest Figures & CAGR of Competitors

Pyridam Farma Tbk PT Glance View

See Also

Company

Help

Tools

Stocks

Pyridam Farma Tbk PT
IDX:PYFA

Pyridam Farma Tbk PT
Other

Pyridam Farma Tbk PT
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Pyridam Farma Tbk PT
Glance View